Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_2
2
29%
Ph not_applicable
1
14%
Ph phase_1
2
29%
Ph phase_4
2
29%

Phase Distribution

2

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(5)
Other(2)

Detailed Status

Completed5
unknown2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (28.6%)
Phase 22 (28.6%)
Phase 42 (28.6%)
N/A1 (14.3%)

Trials by Status

unknown229%
completed571%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_2

Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study

NCT03202667
completedphase_4

SGLT2 Inhibition in Combination With Diuretics in Heart Failure

NCT03226457
completednot_applicable

Alleviating Carbohydrate-Counting Burden in T1DM Using Artificial Pancreas and Empagliflozin

NCT03510000
completedphase_2

Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes

NCT03227484
unknownphase_4

The Effects of Empagliflozin on Arterial Wall Characteristics

NCT03639545
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT03202667Phase 2

Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study

Completed
NCT03226457Phase 4

SGLT2 Inhibition in Combination With Diuretics in Heart Failure

Completed
NCT03510000Not Applicable

Alleviating Carbohydrate-Counting Burden in T1DM Using Artificial Pancreas and Empagliflozin

Completed
NCT03227484Phase 2

Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes

Completed
NCT03639545Phase 4

The Effects of Empagliflozin on Arterial Wall Characteristics

Unknown
NCT03059056Phase 1

Pharmacokinetic Evaluation of Empagliflozin

Completed
NCT02854748Phase 1

Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7